Fund Holdings — Birchview Capital, LP

Total Portfolio Value:
$127.81M
Total Bought:
$9.25M
Total Sold:
$10.23M
Net Transaction:
-$979.2K
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Bristol-Myers Squibb Company(BMY)716,297702,298-13,999$41.57M$36.03M28.19%-$5.54M
Neurocrine Biosciences, Inc.(NBIX)77,24077,2400$8.69M$10.18M7.96%+$1.49M
Biodesix, Inc.(BDSX)5,348,2735,348,2730$8.74M$9.79M7.66%+$1.05M
Acadia Pharmaceuticals Inc240,400240,4000$5.01M$7.53M5.89%+$2.52M
Prothena Corp PlcSHS
SHS
169,574169,5740$8.18M$6.16M4.82%-$2.02M
Immunogen Inc190,000188,000-2,000$3.02M$5.57M4.36%+$2.56M
Quidelortho Corp65,20365,2030$4.76M$4.81M3.76%+$43.0K
Ovintiv Inc.(OVV)84,20084,2000$4.01M$3.70M2.89%-$307.3K
Elutia Inc.(ELUT)1,655,1841,655,1840$2.37M$3.58M2.80%+$1.21M
Phreesia, Inc.(PHR)82,700114,700+32,000$1.54M$2.66M2.08%+$1.11M
United Therapeutics Corporation(UTHR)11,00011,0000$2.48M$2.42M1.89%-$65.8K
Cytokinetics, Incorporated(CYTK)25,00025,0000$736.5K$2.09M1.63%+$1.35M
Foghorn Therapeutics Inc.(FHTX)264,843320,930+56,087$1.32M$2.07M1.62%+$745.8K
Silk Road Medical Inc41,294158,094+116,800$619.0K$1.94M1.52%+$1.32M
Inhibrx Inc70,44848,448-22,000$1.29M$1.84M1.44%+$548.3K
Masimo Corp15,28015,2800$1.34M$1.79M1.40%+$451.2K
Harrow, Inc.(HROW)150,000150,0000$2.16M$1.68M1.31%-$475.5K
10x Genomics, Inc.CL A(TXG)21,00030,000+9,000$866.3K$1.68M1.31%+$812.5K
Corcept Therapeutics Incorporated(CORT)50,00050,0000$1.36M$1.62M1.27%+$261.8K
Alkermes plcSHS(ALKS)50,00050,0000$1.40M$1.39M1.09%-$13.5K
Equitrans Midstream Corporatio133,050133,0500$1.25M$1.35M1.06%+$107.8K
Alphatec Holdings, Inc.(ATEC)80,00088,000+8,000$1.04M$1.33M1.04%+$292.1K
Axogen, Inc.(AXGN)173,000173,0000$865.0K$1.18M0.92%+$316.6K
Stoke Therapeutics, Inc.(STOK)85,000210,000+125,000$334.9K$1.10M0.86%+$769.7K
Protagonist Therapeutics Inc38,00048,000+10,000$633.8K$1.10M0.86%+$466.8K
Travere Therapeutics, Inc.(TVTX)82,000122,000+40,000$733.1K$1.10M0.86%+$363.7K
Apellis Pharmaceuticals Inc
COM
18,00018,0000$684.7K$1.08M0.84%+$392.8K
Accelerate Diagnostics Inc225,239225,2390$1.30M$882.9K0.69%-$412.2K
Pioneer Natural Resources Co3,8003,8000$872.3K$854.5K0.67%-$17.7K
DocGo Inc.(DCGO)130,000150,000+20,000$692.9K$838.5K0.66%+$145.6K
Progyny Inc18,00022,000+4,000$612.4K$818.0K0.64%+$205.6K
Arvinas, Inc.(ARVN)15,00015,0000$294.6K$617.4K0.48%+$322.8K
Kiniksa Pharmaceuticals Ltd30,00030,0000$521.1K$526.2K0.41%+$5.1K
Kalvista Pharmaceuticals Inc40,00040,0000$385.2K$490.0K0.38%+$104.8K
Xenon Pharmaceuticals Inc.(XENE)10,00010,0000$341.6K$460.6K0.36%+$119.0K
Bluebird Bio Inc455,200321,200-134,000$1.38M$443.3K0.35%-$940.6K
Karyopharm Therapeutics Inc.(KPTI)571,832469,832-102,000$766.3K$406.4K0.32%-$359.9K
Amicus Therapeutics Inc
COM
28,00028,0000$340.5K$397.3K0.31%+$56.8K
Halozyme Therapeutics, Inc.(HALO)10,00010,0000$382.0K$369.6K0.29%-$12.4K
Coherus Oncology, Inc.(CHRS)0110,000+110,000$0$366.3K0.29%+$366.3K
Springworks Therapeutics Inc010,000+10,000$0$365.0K0.29%+$365.0K
Biohaven Pharmaceutical Holding Co Ltd07,365+7,365$0$315.2K0.25%+$315.2K
Keros Therapeutics, Inc.(KROS)7,0007,0000$223.2K$278.3K0.22%+$55.2K
Xencor, Inc.(XNCR)12,30012,3000$247.8K$261.1K0.20%+$13.3K
Cullinan Therapeutics, Inc.(CGEM)25,11425,1140$227.3K$255.9K0.20%+$28.6K
G1 Therapeutics Inc120,00080,000-40,000$172.8K$244.0K0.19%+$71.2K
Zentalis Pharmaceuticals, Inc.(ZNTL)016,000+16,000$0$242.4K0.19%+$242.4K
Sarepta Therapeutics, Inc.(SRPT)2,5002,5000$303.1K$241.1K0.19%-$62.0K
Liquidia Corporation(LQDA)020,000+20,000$0$240.6K0.19%+$240.6K
Cabaletta Bio, Inc.(CABA)010,000+10,000$0$227.0K0.18%+$227.0K
Castle Biosciences, Inc.(CSTL)010,000+10,000$0$215.8K0.17%+$215.8K
Wave Life Sciences, Inc.SHS(WVE)040,000+40,000$0$202.0K0.16%+$202.0K
Gossamer Bio, Inc.(GOSS)209,088138,176-70,912$174.1K$126.1K0.10%-$48.0K
BioCryst Pharmaceuticals, Inc.(BCRX)20,00020,0000$141.6K$119.8K0.09%-$21.8K
2seventy Bio Inc59,83319,833-40,000$234.5K$84.7K0.07%-$149.9K
InflaRx N.V.(IFRX)50,00050,0000$149.0K$81.5K0.06%-$67.5K
Ventyx Biosciences Inc26,40028,800+2,400$916.9K$71.1K0.06%-$845.7K
Yield10 Bioscience Inc18,75018,7500$6.1K$4.5K0.00%-$1.6K
NEKTAR THERAPEUTICSCOM(NKTR)28,0000-28,000$16.7K$0—-$16.7K
Page 1 of 1
Birchview Capital, LP — 13F Holdings — Q4 2023 | TickerTrail